Cross-border transactions: A roadmap for commercial arrangements between North American and European companies

Raymond S Fersko
Hind Merabet
Valentina Cordioli

DOI:https://doi.org/10.5912/jcb103

Abstract:

Major advances and breakthroughs in the biotechnology industry are increasingly reached through cross-Atlantic strategic alliances and collaborations. This paper explores some of the distinctions between biotech transactions that are between parties in different countries, particularly the US and EU members.

Keywords:cross-Atlantic transactions ,strategic alliances ,conflict of laws ,intellectual property rights ,en ,